Lai Xu
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 1
- Tuberculosis Research and Epidemiology 1
-
- Cancer Risks and Factors 2
- Cancer Immunotherapy and Biomarkers 2
-
- Erythrocyte Function and Pathophysiology 2
-
- Metabolism, Diabetes, and Cancer 2
-
- HIV Research and Treatment 1
- Co-authors
- Shokrollah ElahiShima ShahbazMohammed OsmanWendy SliglIsobel OkoyeJohn WalkerAfshin NamdarNajmeh Bozorgmehr
- Partner nations
- CanadaChinaUnited States
In The Last Decade
Lai Xu
11 papers receiving 364 citations
Peers
Comparison fields: 5 of 66
- Immunology 146
- Infectious Diseases 115
- Neurology 53
- Genetics 35
- Cancer Research 40
Countries citing papers authored by Lai Xu
This map shows the geographic impact of Lai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lai Xu more than expected).
Fields of papers citing papers by Lai Xu
This network shows the impact of papers produced by Lai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lai Xu. The network helps show where Lai Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lai Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 44 | |
| 2 | 2021 | 76 | |
| 3 | 2021 | 68 | |
| 4 | 2021 | 0 | |
| 5 | 2020 | 19 | |
| 6 | 2020 | 40 | |
| 7 | 2019 | 11 | |
| 8 | 2019 | 32 | |
| 9 | 2017 | 38 | |
| 10 | The involvement of senescence induced by the telomere shortness in the decline of osteogenic differentiation in BMSCs. | 2017 | 14 |
| 11 | 2016 | 26 | |
| 12 | DETECTION OF pncA GENE MUTATION IN MYCOBACTERIUM TUBERCULOSIS | 2009 | 1 |
About Lai Xu
Lai Xu is a scholar working on Virology, Infectious Diseases and Physiology, having authored 12 papers that have together received 369 indexed citations. Recurring topics across this work include Cancer Risks and Factors (2 papers), Erythrocyte Function and Pathophysiology (2 papers), COVID-19 Clinical Research Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Metabolism, Diabetes, and Cancer (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), HIV Research and Treatment (1 paper) and Tuberculosis Research and Epidemiology (1 paper). The work is most often cited by research in Immunology (146 citations), Infectious Diseases (115 citations) and Neurology (53 citations). Lai Xu has collaborated with scholars based in Canada, China and United States. Frequent co-authors include Shokrollah Elahi, Shima Shahbaz, Mohammed Osman, Wendy Sligl, Isobel Okoye, John Walker, Afshin Namdar, Najmeh Bozorgmehr, Michael Joyce and D. Lorne Tyrrell. Their work appears in journals such as The Journal of Immunology, Oncotarget and mBio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.